DMDME Capital Management, LP

Institutional investor · Portfolio as of Q3 2025

Top Holdings37 positions

Checking export access…
Activity:

GREEN BRICK PARTNERS INC

9.5M$699.3M27.5%$60.23+22.63%
7 qtrssince 2024-Q1
Unchanged
0

FLUOR CORP

5.5M$232M9.1%$48.44-13.16%
2 qtrssince 2025-Q2
Increased
82

CORE NATURAL RESOURCES INC

2.2M$180M7.1%$76.54+8.58%
3 qtrssince 2025-Q1
Unchanged
0

BRIGHTHOUSE FINL INC

2.8M$148.2M5.8%$51.56+2.95%
7 qtrssince 2024-Q1
Increased
60

KYNDRYL HLDGS INC

4.3M$130.4M5.1%$24.47+22.71%
7 qtrssince 2024-Q1
Increased
75

PENN ENTERTAINMENT INC

6.8M$130.4M5.1%$18.18+5.95%
7 qtrssince 2024-Q1
Decreased
0

PG&E CORP

6.4M$96.2M3.8%$14.890.00%
1 qtr
New
84

GRAPHIC PACKAGING HLDG CO

4.7M$92.1M3.6%$21.73-13.51%
7 qtrssince 2024-Q1
Unchanged
0

DHT HOLDINGS INC

7.6M$91.1M3.6%$9.09+16.01%
7 qtrssince 2024-Q1
Unchanged
0
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

3.8M$76.3M3.0%$16.70+20.98%
7 qtrssince 2024-Q1
Unchanged
0

WEATHERFORD INTL PLC

960,810$65.7M2.6%$66.93+1.04%
7 qtrssince 2024-Q1
Unchanged
0

CNH INDL N V

5.9M$64.1M2.5%$10.86-1.05%
5 qtrssince 2024-Q3
Decreased
0
GLDGLD
ETF

SPDR GOLD TR

175,101$62.2M2.4%$211.69+67.92%
7 qtrssince 2024-Q1
Increased
53

LIBERTY GLOBAL LTD

5.2M$59.8M2.4%$10.27+11.62%
7 qtrssince 2024-Q1
Unchanged
0

CENTENE CORP DEL

1.6M$55.7M2.2%$47.89-25.50%
4 qtrssince 2024-Q4
Increased
79

CAPRI HOLDINGS LIMITED

2.7M$53.5M2.1%$25.37-21.48%
6 qtrssince 2024-Q2
Decreased
0

VICTORIAS SECRET AND CO

1.9M$52.4M2.1%$23.18+17.08%
2 qtrssince 2025-Q2
Increased
82

SEADRILL LTD

1.6M$48M1.9%$35.83-3.42%
7 qtrssince 2024-Q1
Unchanged
0

ACADIA HEALTHCARE COMPANY IN

1.6M$40.7M1.6%$24.92-0.63%
4 qtrssince 2024-Q4
Increased
73

ROIVANT SCIENCES LTD

2.3M$34.4M1.4%$10.62+42.47%
7 qtrssince 2024-Q1
Decreased
0
$2.5B
AUM
37
Positions
Q3 2025
Filing
HI score · 2.0/5
Quarterly 13F Value Change
-6%Q2'24$2B+18%Q3'24$2.4B-19%Q4'24$1.9B+2%Q1'25$2B+18%Q2'25$2.3B+9%Q3'25$2.5B
Activity profile
$ moved · Q3'25
New29%Increased26%Decreased28%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q11%1-4Q19%1-2Y70%2Y+0%

DME Capital Management, LP manages $2.5B across 37 positions as of Q3 2025. Top holdings: GRBK (27.5%), FLR (9.1%), CNR (7.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.

Q3 2025 Summary

Added 4 new positions, exited 1, increased 9, trimmed 8. Top move: PCG (NEW, conviction 84). Portfolio: $2.5B across 37 positions.

Top holdings by portfolio weight

Total AUM$3B
GRBK27.51%
FLR9.13%
CNR7.08%
BHF5.83%
KD5.13%
PENN5.13%
PCG3.79%
GPK3.62%
DHT3.58%
TEVA3.00%
Other2.59%

Portfolio allocation by GICS sector

Sectors9
Consumer Cyclical41.48%
Energy15.14%
Industrials11.65%
Healthcare10.40%
Technology5.85%
Financial Services5.83%
Utilities3.79%
Unknown2.95%
Communication Services2.93%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Consumer Cyclical, Energy, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L50
Conviction44
Concentration79
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
3Q
GPKGPKGRAPHIC PACKAGING HLDG CO
Q4 2025 → Q2 2026+5.2M shares+$13.1M
3Q
SHCSHCSOTERA HEALTH CO
Q4 2025 → Q2 2026+4M shares+$70.6M
2Q
BKVBKVBKV CORP
Q1 2026 → Q2 2026+1.8M shares+$49.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used